Skip to content
Conference Open access

Quantum AI for Drug Discovery and Material Science

Jul 2026 · Engineering & Technology · pp. 313-327 · 0 citations

TL;DR

This chapter emphasises the advantages of quantum technology in drug discovery: enhanced accuracy in molecular simulations, Accelerated drug screening, better comprehension of reactions, and Tailored medicine.

Abstract

Materials science has historically depended on a blend of experimental methods and theoretical modelling to identify and create new materials with specific properties. Nevertheless, these processes may require considerable time and resources, and are frequently constrained by the intricacy of material systems. The rise of artificial intelligence (AI), particularly machine learning, has revolutionised materials science by offering powerful tools that accelerate the discovery, design, and characterisation of novel materials. This chapter emphasises the latest developments in AI applications in materials science for drug discovery. Artificial Intelligence is proficient at analysing intricate data, enhancing processes, and developing drug candidates, whereas quantum systems enable unparalleled molecular simulations, highly sensitive sensing, and accurate physical control. Applications in drug discovery are emphasised, encompassing molecular property prediction and molecular generation. This chapter focuses on technologies such as Nanomaterials, Biomaterials, Polymers, Metal-Organic Frameworks (MOFs), Hydrogels, and Smart Materials. This chapter emphasises the advantages of quantum technology in drug discovery: enhanced accuracy in molecular simulations, Accelerated drug screening, better comprehension of reactions, and Tailored medicine. Additionally, the challenges include: hardware limitations, the high cost of error correction, the maturity of algorithms, integration with classical methods, and issues related to cost and accessibility.

Read PDF

Similar papers

Review Open access Sep 2026

Quantum computing in drug discovery

A theoretical review of how quantum computation integrates throughout the drug discovery pipeline, from target identification to lead optimisation, and critically distinguishes near-term NISQ capabilities from fault-tolerant quantum computing (FTQC) requirements.

Harshraj N. Gadbail, Rajendra M. Rewatkar, N. Jumde et al. · 0 citations
Review 2026

Perspectives on Hybridizing Quantum Mechanics and Artificial Intelligence for Drug Design.

This chapter presents the perspective of computational chemists at Sygnature Discovery on the growing need to integrate quantum mechanics (QM) with artificial intelligence (AI) to improve the efficiency and effectiveness of modern drug design.

Alexander Heifetz, Girinath G. Pillai, M. Quareshy et al. · 0 citations
Review Jul 2026

Emerging Trends in Artificial Intelligence-Driven Drug Discovery: Balancing Chemical Design and Pharmacological Properties for Cancer Therapy.

This review emphasizes the influence of new AI platforms like AlphaFold3, molecular interactions are structurally optimized (MISATO), and ZairaChem on the discovery of oncology drugs and examines how AI reconciles chemical design with pharmacological feasibility.

Mohsin Ali, Muhammad Ali Tajwar, Farid Ahmed et al. · 0 citations
Review Open access Aug 2026

AI in Drug Development: Applications and Challenges

It is essential to view AI technologies as an instrumental but supplementary part of decision-making in pharmaceutical research and development rather than a fully independent alternative to traditional hit- and lead-discovery strategies.

Saikat Biswas, Somenath Bhattacharya, Soumallya Chakraborty · 0 citations
Review Open access Sep 2026

APPLICATIONS OF DATA ANALYSIS AND ARTIFICIAL INTELLIGENCE AGENTS IN NOVEL DRUG DISCOVERY: A CRITICAL LITERATURE REVIEW

This evidence-based literature review critically examines the evolution and application of computational technologies across the pharmaceutical pipeline, ranging from early expert systems like DENDRAL, computer-aided drug design (CADD), and quantitative structure-activity relationship (QSAR) modeling to AlphaFold 3 bio...

Leonardo Mairene Muniz · 0 citations
#generative ai Review Sep 2026

AI-driven drug discovery and personalized medicine: integrating quantum computing and next-generation technologies

A structured view of current advances, persistent gaps, and future directions in AI-enabled pharmaceutical innovation is offered, showing growing convergence between AI and precision therapeutics, but real-world application demands robust validation, collaboration, explainable AI, and global standards.

M. Fareed, S. Shityakov · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.